Regenxbio Inc. · NASDAQ:RGNX
Pakola Steve sold 15,309 Regenxbio Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Pakola Steve (Chief Medical Officer) sold 15,309 Regenxbio Inc. shares at US$11.02 for US$169K under a trading plan, leaving 232,617 shares. Filed May 13, 2026 (Form 4).
- Sold
- 15,309 shares
- Price
- US$11.02
- Value
- US$169K
- Holding after
- 232,617 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 15,309 | US$11.02 | 232,617 | Direct |
Source
Related
- Regenxbio Inc.
- Pakola Steve
- Regenxbio Inc. shareholders
- Form 4 · Pakola Steve · Aug 4, 2026
- Form 4 · Pakola Steve · Jul 6, 2026
- Form 4 · Pakola Steve · Jul 1, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Malzahn Craig · Sep 3, 2026
- Form 4 · Chan Mitchell · Sep 3, 2026
- Form 4 · Ciongoli Gregory Austin · Aug 27, 2026
- Form 4 · Christmas Patrick J. · Aug 4, 2026